Skye Bioscience, Inc. · NASDAQ:SKYE
Schonfeld Strategic Advisors LLC reported a 5.22% stake in Skye Bioscience, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
Schonfeld Strategic Advisors LLC reported a 5.22% stake in Skye Bioscience, Inc., 1,617,697 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 5.22%
- Shares
- 1,617,697
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 5.22% | 1,617,697 |
Source
Related
- Skye Bioscience, Inc.
- Schonfeld Strategic Advisors LLC
- Skye Bioscience, Inc. shareholders
- Schedule 13G/A · Schonfeld Strategic Advisors LLC · Aug 14, 2025
- Form 4 · Schwab Andrew J. · Sep 24, 2026
- Form 4 · 5AM Ventures II LP · Sep 24, 2026
- Form 4 · Schwab Andrew J. · Sep 18, 2026
- Form 4 · Parmar Kush · Sep 18, 2026
- Form 4 · Schwab Andrew J. · Aug 20, 2026